Quinolone hypersensitivity

Current Opinion in Allergy and Clinical Immunology

Volumn 3, Issue 4, 2003, Pages 275-281

  Campi, Paolo ^a   Pichler, Werner J ^b  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adverse effects; Hypersensitivity quinolones; Specific IgE

Indexed keywords

ANTIBODY; BAY 3118; CIPROFLOXACIN; CLINAFLOXACIN; ENOXACIN; FLEROXACIN; GREPAFLOXACIN; IMMUNOGLOBULIN E; LOMEFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEMAFLOXACIN; TOSUFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; BLOOD CLOTTING DISORDER; CROSS REACTION; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; HEMATOLOGIC DISEASE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOLOGY; INTERSTITIAL NEPHRITIS; OBSTRUCTIVE JAUNDICE; PAPULAR SKIN DISEASE; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

BLOOD COAGULATION DISORDERS; CROSS REACTIONS; DERMATITIS, PHOTOALLERGIC; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; QUINOLONES;

EID: 0042510538     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200308000-00007     Document Type: Review

References (130)

1. Ball P. Future of the quinolones. Semin Respir Infect 2001; 16;215-224.
2. Lucena MI, Andrade RJ, Rodrigo L, et al. Trovafloxacin-induced acute hepatitis. Clin Infect Dis 2000; 30:400-401.
3. Livasy CA, Kaplan AM. Ciprofloxacin-induced toxic epidermal necrolysis: a case report. Dermatology 1997; 195:173-175.
4. Tham TC, Allen G, Hayes D, et al. Possible association between toxic epidermal necrolysis and ciprofloxacin. Lancet 1991; 338:522.
5. Yerasi AB, Oertel MD. Ciprofloxacin-induced toxic epidermal necrolysis. Ann Pharmacother 1996; 30:297.
6. Fuchs S, Simon Z, Brezis M. Fatal hepatic failure associated with ciprofloxacin. Lancet 1994; 343:738-739.
7. Grassmick BK, Lehr VT, Sundareson AS. Fulminant hepatic failure possibly related to ciprofloxacin. Ann Pharmacother 1992; 26:636-639.
8. Helminck R, Benediktsson H. Ciprofloxacin-induced allergic interstitial nephritis. Nephron 1990; 55:432-433.
9. Reece RJ, Nicholls AJ. Ciprofloxacin-induced acute interstitial nephritis. Nephrol Dial Transplant 1996; 11:393.
10. Dutta TK, Badhe BA. Ciprofloxacin-induced bone marrow depression. Postgrad Med J 1999; 75:571-573.
11. De la Torre Lima FJ, Rubio Rubio JM, Garrachon Vallo F, et al. Linfoadenopatìa angioinmunoblȧstica. A propòsito de un caso con manifestaciones clìnicas inusuales y evoluciòn a linfoma T. An Med Intern (Madrid) 1994; 2:442-444.
12. Mouraux A, Gille M, Pieret F, Declercq I. Purpura thrombocytopénique fulminant au decours d'un traitement par ciprofloxacine. Rev Neurol (Paris) 2002; 158:1115-1117.
13. Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS-related complex. BMJ 1988; 298:605.
14. Blum MD, Graham DJ, McCloskey CA. Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 1994; 18:946-950.
15. Gonzales Carro P, Huidobro ML, Zabala AP, Vicente EM. Fatal subfulminant hepatic failure with ofloxacin. Am J Gastroenterol 2000; 95:1606.
16. Pace JL, Gatt P. Fatal vasculitis associated with ofloxacin. BMJ 1989; 299:658.
17. Tafani O, Mazzoli M, Landini G, Alterini B. Fatal acute immune haemolytic anaemia caused by nalidixic acid. BMJ 1982; 285:936.
18. Coleman CI, Spencer JV, Chung JO, Reddy P. Possible gatifloxacin-induced fulminant hepatic failure. Ann Pharmacother 2002; 36:1162-1167.
19. Spahr L, Rubbia-Brandt L, Marinescu O, et al. Acute fatal hepatitis related to levofloxacin. J Hepatol 2001; 35:308-309.
20. Lery N, Zemni M, Carraut J, et al. Mort par syndrome de Lyell après prescription de l'acide pipémidique (Pipram): imputabilité et problèmes mèdico-lègaux. Acta Med Leg Soc 1985; 35:55-61.
21. Arboit F, Bessot JC, De Blay F, et al. L'allergie aux quinolones - à propos de huit observations. Rev Fr Allergol 1997; 37:15-19.
22. Assouad M, Willcourt RJ, Goodman PH. Anaphylactoid reactions to ciprofloxacin. Ann Intern Med 1995; 122:396-397.
23. Baciewicz AM, Georges G, Becker M, Schnall AM. Laryngeal edema related to ciprofloxacin therapy. Ann Pharmacother 1992; 26:1456.
24. Colas C, Pola J, Zapata C, et al. Quinolones hypersensitivity: clinical and immunological aspects [Abstract]. J Allergy Clin Immunol 1993; 91:365.
25. Davila I, Diez ML, Quirce S, et al. Cross-reactivity between quinolones report of three cases. Allergy 1993; 48:388-390.
26. Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989; 111:1041-1043.
27. Deamer RL, Prichard JG, Loman GJ. Hypersensitivity and anaphylactoid reactions to ciprofloxacin. Ann Pharmacother 1992; 26:1081-1084.
28. Gea-Banacloche JC, Metcalfe DD. Ciprofloxacin desensitization. J Allergy Clin Immunol 1996; 97:1426-1427.
29. Kennedy CA, Goetz MB, Mathisen GE. Ciprofloxacin-induced anaphylactoid reactions in patients infected with the human immunodeficiency virus. West J Med 1990; 153:563-564.
30. Lantner RR. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol 1995; 96:1001-1002.
31. Manfredi M, Severino M, Testi S, et al. Specific IgE to quinolones. J Allergy Clin Immunol 2003; (in press).
32. Marsepoil T, Blin F, Lo JM, et al. Un cas de choc anaphylactique à la flumequine. Presse Méd 1985; 14:1712.
33. Miller M. S, Gaido F, Rourk M.H, Spock A. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients. Pediatr Infect Dis J 1991; 10:164.
34. Munoz-Pereira M, Lopez Serrano C, Romualdo L, et al. Anaphylactic reaction by norfloxacin [Abstract]. Allergy 1995; 50 (Suppl. 26):211.
35. Pinzani V, Gennaro G, Petit P, Blayac JP. Chocs anaphylactique et prise de Fluméquine - à propos de 3 cas. Thérapie 1992; 47:440.
36. Ronnau AC, Sachs B, von Schmiedeberg S, et al. Cutaneous adverse reaction to ciprofloxacin: demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro. Acta Derm Venereol 1997; 77:285-288.
37. Seropian E. Imminent shock: a useful diagnosis in drug pathology. Allergol Immunopathol 1976; 4:435-440.
38. Smythe MA, Cappelletty DM. Anaphylactoid reaction to levofloxacin. Pharmacotherapy 2000; 20:1520-1523.
39. Soetikno RM, Johnson J. L, Carey JT. Ciprofloxacin-induced anaphylactoid reaction in a patient with AIDS. Ann Pharmacother 1993; 27:1404.
40. Stricker BHCh, Slagboom G, Demaeseneer R, et al. Anaphylactic reactions to cinoxacin. BMJ 1988; 297:1434-1435.
41. Valdivieso R, Pola J, Losada E, et al. Severe anaphylactoid reaction to nalidixic acid. Allergy 1988; 43:71-73.
42. Vidal C, Suarez J, Martinez M, Gonzalez-Quintela A. Ciprofloxacin-induced glottic angioedema. Postgrad Med J 1995; 71:383.
43. Vieluf D, Russwurm R, Przybilla B, Ring J. Anaphylactoid reactions to quinolones [Abstract]. J Allergy Clin Immunol 1991; 87:228.
44. Wurtz RM, Abrams D, Becker S, et al. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients. Lancet 1989; 1:955-956.
45. Kurata M, Kasuga Y, Nanba E, et al. Flush induced by fluoroquinolones in canine skin. Inflamm Res 1995; 44:461-465.
46. Fernandez M, de las Heras M, Hernandez G, et al. Fixed eruption caused by quinolones [Abstract]. Allergy 1995; 50 (Suppl. 26):211.
47. Reaño M, Vives R, Rodriguez J, et al. Ciprofloxacine-induced vasculitis. Allergy 1997; 52:599-600.
48. Baldo BA, Harle DG. Drug allergenic determinants. Monogr Allergy 1990; 28:11-51.
49. Harle DG, Baldo BA, Smal MA, Fisher MM. Drugs as allergens: the molecular basis of IgE binding to thiopentone. Int Arch Allergy Appl Immunol 1987; 84:277-283.
50. Baran R, Brun P. Photoonycholysis induced by the fluoroquinolones pefloxacine and ofloxacine. Report on 2 cases. Dermatologica 1986; 173:185-188.
51. Alexander S, Forman L. Which of the drugs caused the rash? Or the value of the lymphocyte transformation test in eruptions caused by nalidixic acid. Br J Dermatol 1971; 84:429-434.
52. Bilsland D, Douglas WS. Sunbed pseudoporphyria induced by nalidixic acid. Br J Dermatol 1990; 123:547.
53. Birkett DA, Garretts M, Stevenson CJ. Phototoxic bullous eruptions due to nalidixic acid. Br J Dermatol 1969; 81:342-344.
54. Brauner GJ. Bullous photoreaction to nalidixic acid. Am J Med 1975; 58:576-580.
55. Correia O, Delgado L, Barros MA. Bullous photodermatosis after lomefloxacin. Arch Dermatol 1994; 130:808-809.
56. Granowitz EV. Photosensitivity rash in a patient being treated with ciprofloxacin. J Infect Dis 1989; 160:910.
57. Highet A. Bullous eruption associated with cinoxacin and long wave ultraviolet A light. BMJ 1986; 292:732.
58. Kawabe Y, Mizuno N, Sakakibara S. Photoallergic reaction caused by enoxacin. Photodermatology 1989; 6:57-59.
59. Kimura M, Kawada A, Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin. Contact Dermatit 1998; 38:180.
60. Kurumaji Y, Shono M. Scarified photopatch testing in lomefloxacin photosensitivity. Contact Dermatit 1992; 26:5-10.
61. Poh-Fitzpatrick MB. Lomefloxacin photosensitivity. Arch Dermatol 1994; 130:261.
62. Puissant A, Chef-Cheikh JL, David V. Nouveaux cas de toxidermies à l'acide nalidique. Bull Soc Fr Dermatol Syphiligr 1969; 76:84-85.
63. Thivolet J, Perrot H, Pellerat J, Claudy A. Toxidermie à l'acide nalidique (negram). A propos de 3 cas. Bull Soc Fr Dermatol Syphiligr 1970; 77:286-288.
64. Tokura Y, Seo N, Ohshima A, et al. Lymphocyte stimulation test with drug-photomodified cells in patients with quinolone photosensitivity. J Dermatol Sci 1999; 21:34-41.
65. Maguire RB, Stroncek DF, Gale E, Yearlsey M. Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am J Hematol 1994; 46:363-366.
66. Norrby SR, Lietman PS. Safety and tolerability of fluoroquinolones. Drugs 1993; 45 (Suppl. 3):59-64.
67. Gilbertson C, Rowley Jones D. Haemolytic anaemia with nalidixic acid. BMJ 1972; 4:493.
68. Meyboom RHB. Thrombocytopenia induced by nalidixic acid. BMJ 1984; 289:962.
69. Odeh M, Oliven A, Bassan H. Nalidixic acid-induced hemolytic anemia complicating halothane-induced hepatitis. Isr J Med Sci 1992; 28:294-295.
70. Perez Varga L, Salas Gonzales C. Haemolytic anaemia after nalidixic acid. Lancet 1967; 2:97-98.
71. Denis JP, Martin C, Gouin F. Absence de récidive, sous ciprofloxacine, d'une thrombopénie induite per la péfloxacine. Ann Fr Anesth Reanim 1992; 11:726.
72. Gales BJ, Sulak LB. Severe thrombocytopenia associated with alatrofloxacin. Ann Pharmacother 2000; 34:330-334.
73. Girardin E, Vial T, Mornex R, Evreux JC. Thrombopénie à l'acide pipémidique. Therapie 1992; 47:166-167.
74. MacKay AD, Mehta A. Autoimmune haemolytic anaemia associated with ciprofloxacin. Clin Lab Haematol 1995; 17:97-98.
75. Rosolen A, Drigo P, Zanesco L. Acute hemiparesis associated with ciprofloxacin. BMJ 1994; 309:1411.
76. Teh C, McKendrick M. Ciprofloxacin-induced thrombocytopenia. J Infect 1993; 27:213-215.
77. Chichmanian RM, Spreux A, Bernard E, et al. Thrombopenies dues à la pefloxacine (Peflacine): une toxicité dose-dependante? Therapie 1992; 47:419-421.
78. Choo PW, Gantz NM. Reversible leukopenia related to ciprofloxacin therapy. South Med J 1990; 83:597.
79. Castaman G, Rodeghiero F. Acquired transitory von Willebrand syndrome with ciprofloxacin. Lancet 1994; 343:492.
80. Van Beek EJ, Peters M, ten Cate JW. Factor VIII inhibitor associated with ciprofloxacin. Thromb Haemost 1993; 69:403.
81. Gamboa F, Rivera JM, Gomez Mateos JM, Gomez-Graz E. Ciprofloxacin-induced Henoch-Schonlein purpura. Ann Pharmacother 1995; 29:84.
82. Allon M, Lopes E, Kyung-Whan M. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150:2187-2189.
83. Andrews PA, Robinson GT. Intravascular haemolysis and interstitial nephritis in association with ciprofloxacin. Nephron 1999; 83:359-360.
84. Arvieux C, Charasse C, Guilhem I, et al. Insuffisance rénale aigue par néphropathie tubulo-interstitielle aprés traitement par ciprofloxacine. Ann Med Interne 1991; 142:554-556.
85. Bailey JR, Trott SA, Philbrick JT. Ciprofloxacin-induced acute interstitial nephritis. Am J Nephrol 1992; 12:271-273.
86. Bald M, Ratjen F, Nikolaizik W, Wingen AM. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. Pediatr Infect Dis J 2001; 20:320-321.
87. Boelaert J, de Jaegere PP, Daneels R, et al. Case report of renal failure during norfloxacin therapy. Clin Nephrol 1986; 25:272.
88. Connor JP, Curry JM, Selby TL, Perlmutter AD. Acute renal failure secondary to ciprofloxacin use. J Urol 1994; 151:975-976.
89. Espiritu J, Walton T. Acute renal failure due to ofloxacin. W V Med J 1995; 91:16.
90. Gauffre A, Mircheva J, Glotz D, et al. Autoantibodies against a kidney-liver protein associated with quinolone-induced acute interstitial nephritis or hepatitis. Nephron Dial Transplant 1997; 12:1961-1962.
91. Godin M, Ducastelle T, Bercoff E, et al. Renal failure and quinolone. Nephron 1984; 37:70-72.
92. Gonski PN. Ciprofloxacin-induced renal failure in an elderly patient. Med J Aust 1991; 154:638-639.
93. Hadimeri H, Almroth G, Cederbrant K, et al. Allergic nephropathy associated with norfloxacin and ciprofloxacin. Report of two cases and review of the literature. Scand J Urol Nephrol 1997; 31:481-485.
94. Hootkins R, Fenves AZ, Stephens MK. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature. Clin Nephrol 1989; 32:75-78.
95. Lee CW, Fialkow RZ, Van Wick D. Letter. Am J Kidney Dis 1989; 13:510-511.
96. Lien YH, Hansen R, Kern W, et al. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis. Am J Kidney Dis 1993; 22:598-602.
97. Lo WK, Rolston KV, Rubenstein EB, Bodey GP. Ciprofloxacin-induced nephrotoxicity in patients with cancer. Arch Intern Med 1993; 153:1258-1262.
98. Lucena MI, Marquez M, Velasco JL, Andrade RJ. Acute renal failure attributable to ciprofloxacin in a patient with the acquired immunodeficiency syndrome. Arch Intern Med 1995; 155:114-115.
99. Murray KM, Wilson MG. Suspected ciprofloxacin-induced interstitial nephritis. DICP Ann Pharmacother 1990; 24:379-380.
100. Nakamura M, Ohishi A, Aosaki N, Hamaguchi K. Norfloxacin-induced acute interstitial nephritis. Nephron 2000; 86:204-205.
101. Raja N, Miller WE, McMillan R, Mason JR. Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue. Bone Marrow Transplant 1998; 21:1283-1284.
102. Rastogi S, Atkinson JL, McCarthy JT. Allergic nephropathy associated with ciprofloxacin. Mayo Clin Proc 1990; 65:987-989.
103. Rippelmeyer DJ, Synhavsky A. Ciprofloxacin and allergic interstitial nephritis. Ann Intern Med 1988; 109:170.
104. Rosado LJ, Siskind MS, Copeland JG. Acute interstitial nephritis in a cardiac transplant recipient receiving ciprofloxacin. J Thorac Cardiovasc Surg 1994; 107:1364.
105. Rossi E, Silvestri MG, Manari A, et al. Acute renal failure and piromidic acid. Nephron 1982; 32:80-82.
106. Shih DJ, Korbet SM, Rydel JJ, Schwartz MM. Renal vasculitis associated with ciprofloxacin. Am J Kidney Dis 1995; 26:516-519.
107. Ying LS, Johnson CA. Ciprofloxacin-induced interstitial nephritis. Clin Pharm 1989; 8:518-521.
108. Lomaestro BM. Fluoroquinolone-induced renal failure. Drug Safety 2000; 22:479-485.
109. Amitrano L, Gigliotti T, Guardascione MA, Ascione A. Acute cholestatic liver injury induced by enoxacin. J Hepatol 1993; 18:139-140.
110. Bataille L, Rahier J, Geubel A. Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease. J Hepatol 2002; 37:696-699.
111. Bjornsson E, Olsson R, Remotti H. Norfloxacin-induced eosinophilic necrotizing hepatitis. Am J Gastroenterol 2000; 95:3662-3664.
112. Blum A. Ofloxacin-induced acute severe hepatitis. South Med J 1991; 84:1158.
113. Chen HJ, Bloch KJ, Maclean JA. Acute eosinophilic hepatitis from trovafloxacin. N Engl J Med 2000; 342:359-360.
114. Contreras MA, Luna R, Mulero J, Andreu JL. Severe cirpofloxacin-induced acute hepatitis. Eur J Clin Microbiol Infect Dis 2001; 20:434-435.
115. Hautekeete ML, Kockx MM, Naegels S, et al. Cholestatic hepatitis related to quinolones: a report of two cases. J Hepatol 1995; 23:759-760.
116. Henann NE, Zambie MF. Gatifloxacin-associated acute hepatitis. Pharmacotherapy 2001; 21:1579-1582.
117. Hofer T, Becker EW, Weigand K, Berg PA. Demonstration of sensitized lymphocytes to tremethoprim/sulfamethoxazole and ofloxacin in a patient with cholestatic hepatitis. J Hepatol 1992; 15:262-263.
118. Jones SF, Smith RH. Quinolones may induce hepatitis. BMJ 1997; 314:869.
119. Karim A, Ahmed S, Rossoff LJ, et al. Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease. Clin Infect Dis 2001; 33:2088-2090.
120. Lazarczyk DA, Goldstein NS, Gordon SC. Trovafloxacin hepatotoxicity. Dig Dis Sci 2001; 46:925-926.
121. Levinson JR, Kumar A. Ciprofloxacin induced cholestatic jaundice: a case report [Abstract]. Am J Gastroenterol 1993; 88:1619.
122. Lucena MI, Andrade MJ, Sanchez-Martinez H, et al. Norfloxacin-induced cholestatic jaundice. Am J Gastroenterol 1998; 93:2309-2311.
123. Romero-Gomez M, Suarez Garcia E, Fernandez MC. Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis. Am J Gastroenterol 1999; 94:2324-2325.
124. Sherman O, Beizer JL. Possible ciprofloxacin-induced acute cholestatic jaundice. Ann Pharmacother 1994; 28:1162-1164.
125. Soto S, Lopez-Roses L, Avila S, et al. Moxifloxacin-induced acute liver injury. Am J Gastroenterol 2002; 97:1853-1854.
126. Villeneuve JP, Davies C, Cote J. Suspected ciprofloxacin-induced hepatotoxicity. Ann Pharmacother 1995; 29:257-259.
127. Alonso M, Martin J, Quirce S, et al. Fixed drug eruption caused by ciprofloxacin with cross sensitivity to norfloxacin. Allergy 1993; 48:296-297.
128. Drago F, Arditi MR, Rebora A. Henoch-Schönlein purpura induced by fluoroquinolones. Br J Dermatol 1994; 131:448.
129. Kawada A, Hiruma M, Morimoto K, et al. Fixed drug eruption induced by ciprofloxacin followed by ofloxacin. Contact Dermatit 1994; 31:182-183.
130. Depta J, Pichler WJ. Crossreactivity to drugs. Curr Opin Allergy Clin Immunol 2003; (in press).